HealthEquity (HQY) Misses Q4 EPS by 3c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/12/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- Houthi strike on Saudi airport kills 12, worst attack on kingdom in a decade
- US consumer sentiment near record low as frustration over economy mounts
- One dead in new attack on Saudi airport, a day after Houthi strike kills 13
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake shakes nation, but avoids major destruction
BTIG Reiterates Buy Rating on HealthEquity, Inc (HQY)
March 19, 2025 4:53 AM EDTBTIG analyst David Larsen reiterated a Buy rating and $130.00 price target on HealthEquity, Inc (NASDAQ: HQY).
The analyst comments "On Tuesday, 3/18/25 AMC, HQY reported F4Q:25 results. Total revenue of $311.8M +19% y/y was well ahead of BTIG / consensus estimates of $306.8M / $306M but adjusted EBITDA of $107.8M +9% y/y missed BTIG... More



